Accelerated TMS vs. antidepressants: why TMS works in weeks, not months

Antidepressants require four to eight weeks of daily use before most people feel meaningful relief. TMS therapy (transcranial magnetic stimulation) can produce noticeable improvement in one to three weeks, and accelerated TMS protocols like the SAINT method compress a full treatment course into five days. The difference comes down to how each approach changes the brain: antidepressants gradually adjust neurochemistry through receptor adaptation, while TMS directly stimulates neuroplasticity in the brain’s mood circuits.

If you’re weighing these timelines because you need to feel better soon, whether for work, school, or daily functioning, here’s what the science says about how fast each treatment works and why.

Why antidepressants take four to eight weeks

SSRIs and SNRIs, the most commonly prescribed antidepressants, block the serotonin transporter almost immediately after the first dose. But that initial chemical change isn’t what relieves depression. The therapeutic effect depends on a slower biological process called receptor downregulation: the brain must gradually reduce the number of certain serotonin receptors (called 5-HT1A autoreceptors) in response to the increased serotonin levels. According to the Psychopharmacology Institute, this downregulation is “mediated by genomic mechanisms” and takes weeks to occur.

In practical terms, here’s what that timeline looks like:

Weeks 1 to 2: Side effects like nausea, insomnia, or dizziness often appear before any mood improvement.

Weeks 3 to 4: Some people begin noticing subtle shifts in energy or emotional reactivity.

Weeks 6 to 8: Full therapeutic benefit becomes apparent for those who respond to the medication.

And if the first medication doesn’t work, which happens often? A reanalysis of the STAR*D trial, the largest antidepressant study ever conducted, found a remission rate of only 35% after patients tried four different antidepressants. By the third and fourth medication trials, remission rates dropped to approximately 12-14% per step, with each successive switch offering diminishing likelihood of relief. Each new trial means another six-to-eight-week wait.

This isn’t a flaw in the medications. It’s a limitation of how they work. Antidepressants modulate monoamines (serotonin, norepinephrine, dopamine) indirectly, relying on the brain’s own adaptation timeline. That timeline simply can’t be rushed.

Why TMS works in weeks, not months

TMS takes a fundamentally different approach. Instead of adjusting neurochemistry from the inside and waiting for the brain to adapt, TMS directly depolarizes neurons in the left dorsolateral prefrontal cortex (DLPFC), the region most consistently linked to mood regulation in depression.

This direct stimulation triggers a cascade of neuroplastic changes:

Long-term potentiation (LTP): Repeated magnetic pulses strengthen synaptic connections between neurons, similar to how learning strengthens neural pathways.

BDNF release: TMS appears to influence brain-derived neurotrophic factor (BDNF), a protein that supports neuron growth and survival. A 2024 clinical trial review published in MDPI found evidence suggesting an increase in serum BDNF following TMS in several studies, though the overall effect across all trials remains an active area of investigation.

Gray matter changes: Neuroimaging research suggests that repeated TMS sessions can increase gray matter volume in brain regions associated with mood regulation, reflecting the structural neuroplastic changes the treatment promotes.

The key distinction: antidepressants wait for the brain to reorganize itself in response to changed chemistry. TMS directly reorganizes the circuits. That’s why the timeline is measured in days and weeks rather than months.

What improvement typically looks like, week by week

Individual experiences vary, and we always encourage people to discuss expectations with their care team. That said, clinical observations and member reports suggest a general pattern:

Days 1 to 3: Many people notice changes in sleep quality first. Falling asleep becomes easier, or sleep feels more restorative.

Week 1: Shifts in motivation and energy. Tasks that felt overwhelming may start to feel manageable. Some describe it as “the fog lifting slightly.”

Week 2: Social re-engagement. People may find themselves initiating conversations, accepting invitations, or feeling less drained by interaction.

Week 3 and beyond: Broader symptom relief, including sustained improvements in mood, concentration, and daily functioning.

A 2025 retrospective study in the Journal of Affective Disorders tracking weekly TMS response trajectories found that “each additional week of TMS treatment increased response and remission odds more than 1.5-fold,” with large effect sizes (Hedges’ g > 0.9). The improvement tends to be gradual but cumulative, building week over week rather than arriving all at once.

Accelerated TMS protocols: which timeline fits your life?

Not all TMS protocols follow the same schedule. Four main options exist, each with different time commitments and cost considerations.

Standard rTMS

Standard repetitive TMS involves daily sessions, five days a week, for four to six weeks (20 to 36 total sessions). Each session lasts about 37 to 45 minutes. This is the most widely available and most commonly insurance-covered protocol.

Timeline: 4 to 6 weeks

Session length: 37 to 45 minutes

Total sessions: 20 to 36

Cost: $6,000 to $15,000 (often covered by insurance after one antidepressant failure)

Remission rate: Approximately 30%, with about 50% of people experiencing meaningful improvement, according to Stanford Medicine data

Intermittent theta burst stimulation (iTBS)

iTBS was FDA-cleared in 2018 as a faster variant of TMS for treatment-resistant depression. The stimulation time drops to roughly 3 minutes per session compared to 19 to 37 minutes for standard rTMS. A 2023 systematic review in Psychiatry Research confirmed that “a 3-min iTBS treatment protocol with 600 pulses per session achieves a similar effect on neural plasticity as the 37.5-min HF-rTMS treatment.”

Timeline: 4 to 6 weeks (same number of sessions, shorter each day)

Session length: About 3 minutes of active stimulation

Total sessions: 20 to 36

Cost: Similar to standard rTMS; some insurance plans cover iTBS

Best for: People who need to fit treatment around a work or school schedule

ONE-D protocol (one-day accelerated TMS)

The ONE-D protocol (Optimized, Neuroplastogen-Enhanced Depression treatment) compresses an entire course of iTBS into a single day. Members receive 20 iTBS sessions over roughly 9.5 hours, spaced 30 minutes apart, with a single dose of d-cycloserine (125 mg) and lisdexamfetamine (20 mg) given one hour before treatment to support neuroplasticity.

A 2025 retrospective case series published in Brain Stimulation involving 32 adults with depression found the regimen to be “feasible, safe, well tolerated, and associated with clinically meaningful improvement,” with effects sustained at 3 to 6 months. One important distinction from SAINT: the ONE-D treatment schedule itself is not separately FDA-approved, though the underlying iTBS protocol is FDA-cleared. Full symptom improvement typically reaches its peak 4 to 6 weeks after the treatment day, even though the sessions happen in a single sitting.

Timeline: 1 day (approximately 9.5 hours)

Session length: 20 sessions, each ~3 minutes of active stimulation, spaced 30 minutes apart

Total sessions: 20

Cost: Varies by clinic; typically private-pay only

Best for: People who cannot commit to multiple weeks of daily visits and want to complete treatment in one clinical day

You can read more about this approach in our guide to one-day TMS in Manhattan.

The SAINT protocol (Stanford Accelerated Intelligent Neuromodulation Therapy)

SAINT compresses the full TMS treatment course into five consecutive days. Developed by Dr. Nolan Williams at Stanford University, the protocol delivers 10 iTBS sessions per day, spaced 50 minutes apart, for a total of 90,000 magnetic pulses over five days. Each person receives a functional MRI (fMRI) scan beforehand so treatment targets the precise spot on the DLPFC most strongly connected to their mood-regulating circuits.

The FDA cleared SAINT in 2022 for treatment-resistant depression. In a double-blind randomized controlled trial published in the American Journal of Psychiatry (2022), active treatment produced a remission rate of 78.6%, compared to 13.3% for the sham group. These figures reflect participants who met remission criteria at any point during the four-week follow-up period. An earlier open-label study found that the mean time to treatment response was approximately 2 to 3 days after starting the protocol.

Timeline: 5 days

Session length: 10 sessions per day, each about 10 minutes, with 50-minute breaks

Total sessions: 50

Cost: $30,000 to $36,000 at most clinics; CMS approved hospital reimbursement of $19,703 starting in 2025

Best for: People who need the fastest possible relief and can commit to five full days

Comparing your options at a glance

Protocol Treatment duration Session length Remission rate Typical cost Insurance coverage
Standard rTMS 4 to 6 weeks 37 to 45 min ~30% $6,000 to $15,000 Widely covered
iTBS 4 to 6 weeks ~3 min Similar to rTMS $6,000 to $15,000 Growing coverage
ONE-D 1 day ~3 min x 20 Emerging data Varies (private-pay) Not yet covered
SAINT 5 days 10 min x 10/day ~79% $30,000 to $36,000 Limited (expanding)

What TMS therapy costs and how to pay for it

Cost is one of the biggest questions people have about TMS therapy for depression, and the answer depends on which protocol you choose and your insurance situation.

Standard rTMS and iTBS are the most accessible options financially. Most major insurance plans now cover TMS for depression after at least one antidepressant has been tried without adequate improvement. Out-of-pocket costs for uninsured members typically range from $6,000 to $15,000 for a full course, according to CareCredit’s 2024 analysis, with individual sessions averaging $300 to $500.

The SAINT protocol carries a higher upfront cost ($30,000 to $36,000 at most clinics). Insurance coverage is currently limited, though expanding. In November 2024, the Centers for Medicare and Medicaid Services (CMS) approved a new payment rate of $19,703 for the complete SAINT protocol in hospital outpatient settings, with new billing codes taking effect in 2025.

When evaluating cost, it’s worth considering the full picture. Eight or more weeks of reduced work performance, missed days, or delayed career decisions carry their own financial weight. For some people, a five-day intensive protocol, even at a higher price point, may cost less than months of partial functioning.

Getting back to your life: the return-to-work timeline

For adults managing depression while working or attending school, speed matters beyond symptom relief. It affects income, career trajectory, and academic standing.

Here’s how the return-to-function timeline typically looks with TMS treatment:

Week 1: Many people can manage daily responsibilities, including work, during standard TMS treatment. Sessions are outpatient, and most report feeling well enough to drive and work the same day.

Weeks 1 to 2: Partial restoration of professional functioning. Members often describe being able to manage meetings, respond to emails, and maintain basic productivity.

Week 3 and beyond: Full professional capacity for most responders. Concentration, decision-making, and interpersonal engagement typically normalize.

With the SAINT protocol, this timeline compresses further. Because the full treatment happens over five days (Monday through Friday), some people schedule it like a work trip and return to their regular routine the following week.

Standard TMS doesn’t require time off work either. Sessions fit into a lunch break or morning appointment, especially with iTBS’s 3-minute active stimulation time.

TMS therapy side effects: what to expect

TMS therapy side effects are generally mild and temporary. The most common are:

  • Scalp discomfort or tenderness at the treatment site during or shortly after sessions
  • Mild headaches, which usually resolve within the first few sessions
  • Brief lightheadedness

These tend to lessen after the first week of treatment. Serious adverse events like seizures are rare when members are properly screened, which is why medical evaluation before beginning treatment is so important.

Unlike antidepressants, TMS does not cause weight gain, sexual dysfunction, nausea, or the “emotional blunting” that some people report with SSRIs. There’s also no withdrawal or tapering period when treatment ends.

When to consider TMS over antidepressants

TMS may be worth exploring if:

  • You’ve tried one or more antidepressants without adequate relief
  • Side effects from medication are affecting your quality of life
  • You need faster symptom improvement than the 4-to-8-week antidepressant timeline allows
  • You prefer a time-limited treatment course over indefinite daily medication

TMS isn’t the right fit for everyone. People with certain metal implants or a history of seizures may not be candidates. A thorough medical evaluation is the first step in determining whether TMS is appropriate for your situation.

If you’re interested in learning more about rapid TMS treatment options, including which protocol might fit your timeline and budget, our care team can walk you through the process. Book a consultation to discuss your options.

FAQs

How quickly does TMS start working compared to antidepressants?

Most people notice initial improvements from TMS within one to two weeks, with broader relief by week three. Antidepressants typically require four to eight weeks for full therapeutic effect, and if the first medication doesn’t work, each additional trial adds another six to eight weeks.

Is accelerated TMS as effective as standard TMS?

Research suggests accelerated protocols may be more effective. The SAINT protocol, which compresses treatment into five days, achieved a 78.6% remission rate in a double-blind randomized controlled trial published in the American Journal of Psychiatry (2022), compared to approximately 30% for standard rTMS protocols.

What does TMS therapy cost, and does insurance cover it?

Standard rTMS typically costs $6,000 to $15,000 and is covered by most major insurance plans after at least one unsuccessful antidepressant trial. The SAINT protocol costs $30,000 to $36,000 at most clinics, with insurance coverage currently limited but expanding. CMS approved hospital reimbursement of $19,703 for SAINT starting in 2025.

Can I work during TMS treatment?

Yes. TMS is an outpatient procedure, and most people continue working throughout treatment. Standard sessions last 20 to 45 minutes, and iTBS sessions take about 3 minutes of active stimulation. Most members drive themselves to and from appointments and return to their normal activities the same day.

What are the side effects of TMS therapy?

The most common TMS therapy side effects are mild scalp discomfort and headaches during or shortly after the first few sessions. These typically resolve within the first week. Unlike antidepressants, TMS does not cause weight gain, sexual dysfunction, or emotional blunting, and there is no withdrawal period when treatment ends.

Nushama

Discover What Psychedelic Medicine Can Do for You

To transcend depression, anxiety, alcohol use disorders, and trauma-induced mood disorders, Nushama offers IV ketamine for an ego-dissolving psychedelic experience. A holistic path of mindful intention setting, ketamine journeys, and thoughtful integration in safe, healing-focused settings empower members to reset and reconnect.

Explore Our Blog